Ingersoll Rand Inc (IR)
Fair ValueFundamental
72
Price
$75.11
Market Cap
$29.64B
Part 1 · What the company is worth
Overview
Ingersoll Rand Inc. provides mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services a range of air and gas compression and treatment equipment, vacuum and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment; and other specialized equipment, including aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. It sells its products through a network of direct sales representatives and independent distributors. It has a strategic alliance with Garrett Motion. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on September 18, 2026 with claude-haiku-4-5 — shared with all users
IDEX competes with Ingersoll Rand in both of its segments, selling industrial pumps and fluid-handling equipment as well as precision dosing and metering pumps for life sciences and medical applications.
Dover's pump and fluid-transfer businesses compete with Ingersoll Rand's Precision and Science Technologies segment for the same customers in industrial dosing, biopharma and medical fluid handling.
Graco makes fluid-handling pumps and dispensing equipment, and Ingersoll Rand lists it as a primary competitor for the precision pump and metering customers served by its Precision and Science Technologies segment.
Atlas Copco is the world's largest maker of industrial air compressors, vacuum pumps and blowers and meets Ingersoll Rand head-on in the same factories and plants that buy compressed-air systems and their aftermarket service.
Kaeser is a privately held German manufacturer of rotary-screw compressors and blowers sold to the same industrial customers, and Ingersoll Rand names it as a principal competitor in its compression business.
Flowserve supplies industrial pumps and flow-control equipment to the same process, chemical and energy plants that buy Ingersoll Rand's compression and fluid-handling products, including the aftermarket parts and service that follow.
Balance Sheet & Liquidity
Revenue
$7.94B
Trailing 12 months (through 6/30/2026)
Net Income
$959M
Trailing 12 months (through 6/30/2026)
Free Cash Flow
$1.22B
Total Equity
$10.09B
Total Liabilities
$8.14B
Current Ratio
1.62
Interest Coverage
5.58
Debt/EBITDA
2.93
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$62.83
Current Price
$75.11
Margin of Safety
-19.5%
Fair Value Range
$40.84 - $84.83
Spread across the valuation methods used, not a statistically calibrated confidence interval.
Estimation Methods
Valuation Metrics
P/E Ratio
30.91
ROE
5.8%
P/B Ratio
2.86
P/FCF
23.90
Gross Margin
42.8%
ROIC
7.3%
Profitability Radar
Value Creation (Economic Moat)
ROIC
7.3%
WACC
10.0%
ROIC − WACC
-2.6 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Fundamental Analysis Criteria
Passed (21)
- EPS shows upward trend
- Price CAGR 8.87%
- ROIC 7.3%
- Gross Margin 42.8%
- P/FCF 23.90
- P/B Ratio 2.86
- Debt/Equity ratio
- Operating Margin 18.1%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 9.5%
- Revenue Growth 5Y 14.0%
- Analyst Consensus 61% Buy
- Earnings Quality (OCF/NI) 1.41
- Share Dilution -1.5%
- Net Margin Trend 12.1% vs 7.1%
- Piotroski F-Score 5/9
Failed (4)
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Earnings Surprise avg -0.1%
Unavailable (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Mixed signals: some areas need attention
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Institutional Holdings
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Mr. Vicente Reynal | Chairman, CEO & President | 50 |
| Mr. Vikram U. Kini | Senior VP & CFO | 44 |
| Mr. Andrew R. Schiesl Esq. | Senior VP, General Counsel, Chief Compliance Officer & Secretary | 53 |
| Ms. Kathleen M. Keene | Senior VP & Chief Human Resources Officer | 50 |
| Mr. Michael A. Weatherred | Senior Vice President of Ingersoll Rand Execution Excellence (IRX), Business & Commercial Excellence | 63 |
| Mr. Michael J. Scheske | VP & Chief Accounting Officer | 37 |
| Mr. Matthew J. Emmerich | Senior VP & Chief Information Officer | 49 |
| Mr. Matthew Fort | VP of Investor Relations, Global Financial Planning & Analysis | - |
| Ms. Elizabeth Meloy Hepding | Senior Vice President of Corporate Development | 47 |
| Mr. Arnold Li | Senior VP & President of ITS Asia Pacific | - |
Audit Risk
5
Board Risk
7
Compensation Risk
3
Shareholder Rights Risk
5
Part 2 · The price and when to enter
This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Documents
- View document
Annual Report (10-K)
A yearly overview of the business, its financial results, and the risks it faces.
Filed on 2026-02-17
- View document
Quarterly Report (10-Q)
A snapshot of financial performance for the most recent three-month period.
Filed on 2026-07-31
- View document
Current Report (8-K)
An announcement of a major event, such as a leadership change or big news.
Filed on 2026-07-30
via SEC EDGAR
Income History
via SEC EDGAR
Latest News
Recent headlines for IR, sourced from Markets Gazette.